San-Huang-Xie-Xin-Tang (SHXT), composed of Coptidis rhizoma, Scutellariae radix, and Rhei rhizoma, is a
traditional Chinese medicine used for complementary and alternative therapy of cardiovascular and
neurodegenerative diseases via its anti-inflammatory and antioxidative effects. The aim of this study is to investigate the protective effects of SHXT in the
1-methyl-4-phenylpyridinium (MPP(+))/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (
MPTP) models of
Parkinson's disease. Rat primary mesencephalic neurons and mouse
Parkinson disease model were used in this study. Oxidative stress was induced by MPP(+) in vitro and
MPTP in vivo. In MPP(+)-treated mesencephalic neuron cultures, SHXT significantly increased the numbers of TH-positive neurons. SHXT reduced apoptotic signals (
cytochrome and caspase) and apoptotic death. MPP(+)-induced gp91(
phox) activation and ROS production were attenuated by SHXT. In addition, SHXT increased the levels of GSH and SOD in MPP(+)-treated neurons. In
MPTP animal model, SHXT markedly increased TH-positive neurons in the substantia nigra pars compacta (SNpc) and improved motor activity of mice. In conclusion, the present results reveal the evidence that SHXT possesses beneficial protection against
MPTP-induced neurotoxicity in this model of
Parkinson's disease via its antioxidative and antiapoptotic effects. SHXT might be a potentially alternative and
complementary medicine for neuroprotection.